KGHRI researcher co-leads study of improved cancer screening technique

KGHRI molecular geneticist and Queen’s University cancer researcher Harriet Feilotter (Pathology and Molecular Medicine) is co-leading a multi-institutional study with Dr. John Bartlett of the Ontario Institute for Cancer Research (OICR) on the efficacy of a genetic sequencing assay that tests more than 100 genetic mutations in cancer cells. (An assay is a molecular test that looks for biomarkers for diagnosing disease or predicting response to drugs.)

This test could accelerate personalized patient care by linking these mutations to new treatment options.

Your Guidebook to Cancer Care

A guidebook containing practical information about the Cancer Centre of Southeastern Ontario at Kingston General Hospital. It provides information about preparing for appointments, what to expect from treatment, and the cancer care team. It also provides information about where to find support and help. This is a companion to "My Patient Binder".